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E-mail address: fguare@ufba.br (F.G. Cruz).A nicotinic ester with a new carbon skeleton named myrciaine was obtained from hexane extract of
stems of Myrcia blanchetiana using chromatographic methods and from leaves by supercritical CO2.
The molecular structure was established on the basis of extensive NMR studies and HREIMS. Myrciaine
did not display substantial activity against Gram-negative and Gram-positive bacteria neither against
the fungi Aspergillus niger and Cladosporium cladosporioides. Density functional theory (DFT) methods
were applied to analyze the stability of two possible conformational structures. The calculated relative
energy between the optimized conformers has conﬁrmed the proposed structure based on the experi-
mental results.
 2013 Elsevier Ltd. All rights reserved.Indigenous tribes and traditional Brazilian communities use
some species of the genus Myrcia as astringent, against diabetes
and diarrhea, as diuretic, to stanch hemorrhages, against the
hypertension and ulcers of the mouth.1 The chemical composition
of non-volatile components from species of this genus is
little-known. Previous studies had revealed the occurrence of euca-
lyptin, a C-methylated ﬂavone, and b-amyrin from Myrcia citrifoli-
a,2 ﬂavanone glycosides, acetophenone glycosides, and ﬂavonols
from Mirabilis multiﬂora.3,4 From the essential oils of eighteen
Myrcia species sesquiterpenes were predominant except forMyrcia
acuminatissima and Mammillaria bombycina for which the
monoterpenes fraction is slightly larger5–8 and for Micromeria
myrtifolia which presented a high content of monoterpenes.9
Myrcia blanchetiana is a wild shrub that occurs in campo rupestre
areas (rocky ﬁelds) near Andaraí, at Chapada Diamantina, Bahia,
northeastern of Brazil, and was in bloom when stems and leaves
were collected. From our knowledge, in the literature there is no
report on its chemical and biological properties or their traditional
use.
In this work we describe the isolation and structure elucidation
of a nicotinic ester with new carbon skeleton from the stems and
leaves of M. blanchetiana. As a complement, DFT calculations at
the B3LYP/6-31G(d,p) level10,11 were performed to investigate the
conformational stability of the isolated compound. Until 2010, noll rights reserved.
ax: +55 071 3237 4117.alkaloid has been isolated from Myrtaceae. In the literature only
one paper describes the detection of alkaloids in Syzygium cumini12
and another describes the isolation of 1,2,3,4-tetrahydro-1-
methyl-b-carboline alkaloid from Calycorectes psidiiﬂorus.13 Thus,
compound 1, named myrciaine, is only the second alkaloid isolated
from a Myrtaceae species.
The dried stems were extracted with hexane to give a brown
gum (945 mg). This extract was submitted to a chromatography
column on silica gel (eluent: from hexane to EtOAc; from EtOAc
to MeOH) to give white crystalline 3b-acetoxi-olean-18-en-28-
oic acid (76 mg) and compound 1 (42 mg) as a colorless gum
½a25D 6.9 (c 0.53, CHCl3). Compound 1, was also observed as the
major component of the extract obtained from leaves after a
selective extraction with supercritical CO2 at 40 C and 2000 psi
by 1 h.
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of the molecular ion peak at m/z 391.1954, in HREIMS and NMR
data. Its IR spectrum showed strong absorptions in 1728, 1288,
and 1242 cm1 indicating the presence of ester. The 1H NMR
spectrum (Table 1) showed four aromatic proton signals at d
9.50 (s, 1H), d 8.82 (d, 1H; 3.9 Hz), d 8.48 (dd, 1H; 8.0 and
1.8 Hz), and d 7.45 (dd, 1H; 8.0 and 4.8 Hz) consistent with a 3-
monosubstituted-pyridine ring. The base peak at m/z 124, corre-
sponding to ion C6H6NO2+ (protonated nicotinic acid) and the
fragment at m/z 106, corresponding to ion C6H4NO+ in the mass
spectrum, suggest the presence of a nicotinic moiety which was
conﬁrmed by 13C NMR data [d 165.1 (COO), d 153.9 (CH), d
151.6 (CH), d 138.0 (CH), d 126.5 (C), and d 123.8 (CH)] (Table 1).
In the aliphatic region, the 1H NMR spectrum showed three
oxymethine proton signals at d 5.33 (t, 1H; 6.6 Hz), d 5.10 (d,
1H; 2.8 Hz), and d 5.04 (d, 1H; 3.1 Hz) with corresponding
13C NMR signals at d 71.1, 78.5, 75.6, respectively. The signals at
d 2.11 (s, 3H) and at d 2.13 (s, 3H) in the 1H NMR spectrum and
at d 21.4 (2  CH3), d 171.1 and 171.3 in the 13C NMR spectrum
suggested the presence of two acetate groups. Two signals in a
complex splitting pattern were observed at d 2.32 and 1.96 which
were assigned for two methine hydrogens between two oxyme-
thine carbons. Four signals assigned to methyl groups were ob-
served as singlet at d 1.20, triplet at d 0.97 (7.4 Hz) in a partial
overlap with a singlet at d 0.95 and this in a partial overlap with
a doublet at d 0.94 (6.1 Hz).
The HOMOCOSY spectrum revealed the connections of the
hydrogens at d 5.10 (H-8) with d 2.32 (H-13); d 2.32 (H-13) with
d 5.10 (H-8), d 5.33 (H-12) and d 0.94 (H-18); d 5.33 (H-12) with
d 2.32 (H-13) and d 1.96 (H-11); d 1.96 (H-11) with d 5.33
(H-12), d 5.04 (H-10) and d 1.36 (H-14), establishing a well deﬁned
splitting pattern among these protons. The carbon skeleton of mol-
ecule and the exact positions of the nicotinoyl and acetyl groups in
the aliphatic moiety were completely established by the connectiv-
ities observed in the HMBC spectrum (Table 1). The cross peaks
showed by the signals of methine protons at d 5.10 (H-8) with
C-7, C-9, C-13, C-12, C-16, and C-18 and those of the signal at
d 5.04 (H-10) with C-8, C-9, C-11, C-12, C-16, C-17, and C-21 per-
mitted to trace the carbon backbone of aliphatic moiety as well
as to locate the positions of one methyl, gem-dimethyl, nicotinoyl,
and one acetyl groups. The localization of the ethyl and of theTable 1
1H, 13C and HMBC data for compound 1
No. 1H (m, J, Hz) 13C HMBC (H to C)
2 9.50 (s) 151.6 3, 4, 6, 7
3 — 126.5 —
4 8.48 (dd, 8.00; 1.8) 138.0 2, 6, 7
5 7.45 (dd, 8.00; 4.8) 123.8 3, 6
6 8.82 (d, 3.9) 153.9 2, 5
7 — 165.1 —
8 5.10 (d, 2.8) 78.5 7, 9, 12, 13, 16, 18
9 — 39.2 —
10 5.04 (d, 3.1) 75.6 8, 9, 11, 12, 16, 17, 21
11 1.96 (m) 41.7 14
12 5.33 (t, 3.3) 71.1 10, 11, 13, 19
13 2.32 (m) 34.6 18
14 1.36 (m) 21.6 10, 11, 12, 15
15 0.97 (t, 7.4) 11.9 11, 14
16 1.20 (s) 25.7 8, 9, 10, 17
17 0.95 (s) 23.3 8, 9, 10, 16
18 0.94 (d, 6.1) 14.3 8, 12, 13
19 — 171.1a —
20 2.13 (s) 21.4 19
21 — 171.3a —
22 2.11 (s) 21.4 21
Mesured at 500 MHz (1H) and 125 MHz (13C) in CDCl3.
a The signals can be changed.reminder acetyl groups in the molecule skeleton was obtained
from the correlations between the signal at d 5.33 (H-12) with
the carbons C-10, C-11, C-13, and C-19 and of the signal at d 0.97
(H-15) with C-11 and C-14.
The relative stereochemistry was established by careful NOE
difference experiments (Fig. 1). The selective irradiation of protons
allowed the establishment of spatial correlations between them,
thus the correlations of H-2 and H-4 with both acetyl-Me H-20
and H-22 suggested that the nicotinoyl and acetyl groups are in
the same face of molecule (a-face). The correlations among the
methyl group H-16 with H-8, H-10, H-11, and H-13 indicated that
these hydrogens are in the b-face of the molecule. The correlations
observed between the hydrogens H-2 and H-4 with both acetyl-Me
as well as the magnitudes of the coupling constants of hydrogens
H-8 (J = 2.8 Hz), H-10 (J = 3.1 Hz), and H-12 (J = 3.3 Hz) are consis-
tent with a molecule in a conformational arrangement where
nicotinoyl and both acetyl groups are in axial. A molecular model
examination demonstrated that a conformation with these groups
in axial positions (Fig. 2A) is, apparently, more stable. The confor-
mation with these groups in equatorial (Fig. 2B) is destabilized due
to a strong 1,3-diaxial repulsion among C-14, C-17, and C-18. To
conﬁrm these ﬁndings, we have optimized the geometry of two
different conformational structures within DFT/B3LYP/6-31G(d,p)
level using the Gaussian 03 program.14 The frequency calculations
indicate that both conformers correspond to minimum energy
structures. The results showed that the molecular structure with
these groups in the axial positions is ca. 10.4 kcal/mol more stable
than the structure with nicotinoyl and both acetyl groups in the
equatorial positions. The results also revealed that the exocyclic
C–O bond of both acetyl and nicotinoyl groups are eclipsed due
to repulsions between the carbonyls and equatorial substituents
on the adjacent carbons while the carbonyls are in a synperiplanar
arrangement with oxymethine hydrogen.15
Compound 1 did not display substantial activity (IC50
>100 lM) when tested against the Gram-negative bacteria Esche-
richia coli (ATCC 94863), Salmonella choleraesuis (ATCC 14028), and
Pseudomonas aeruginosa (obtained of an isolate in the Faculty of
Pharmacy - UFBA), Gram-positive bacteria Streptococcus mutans
(ATCC 5175), Staphylococcus aureus (ATCC 6538), Bacillus subtilis
(ATCC 6633), and Micrococcus luteus (ATCC 10240) or the fungi
Aspergillus niger (ATCC 16404) and Cladosporium cladosporioides
(IMI 178517).
A possible pathway to the biosynthesis of myrciaine was delin-
eated in Scheme 1.The alternating oxygenation pattern of aliphatic
moiety suggested that it could have been synthesized from four
units of AcCoA (Scheme 1). This is a plausible assumption by the
fact that some Myrtaceae species produce acetophenones.4,16 Sub-
sequently, three successive methylations with SAM, reduction of
carbonyl and esteriﬁcations with AcCoA and nicotinoyl-CoA led
to the formation of compound 1.O
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Figure 1. Some important NOE interactions of compound 1.
Figure 2. Optimized structures of two isomers obtained at the B3LYP/6-31G(d,p) level of theory. The calculated relative energy between isomers A and B is of 10.4 kcal/mol.
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Scheme 1. Proposed biogenesis for compound 1.
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